ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional Accepts healthy volunteers

CROSSOVER STUDY OF ON-DEMAND PREP FORMULATIONS COMPARING RECTAL AND ORAL TENOFOVIR

ClinicalTrials.gov ID: NCT06560684

Public ClinicalTrials.gov record NCT06560684. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 24, 2026, 11:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 2 CROSSOVER STUDY OF ON-DEMAND PREP FORMULATIONS COMPARING RECTAL AND ORAL TENOFOVIR-BASED PREP EVALUATING EXTENDED SAFETY, ACCEPTABILITY, AND PHARMACOKINETICS/PHARMACODYNAMICS

Study identification

NCT ID
NCT06560684
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
150 participants

Conditions and interventions

Conditions

Interventions

  • Oral F/TDF Pills Drug
  • TFV rectal douche Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 28, 2024
Primary completion
May 14, 2026
Completion
May 14, 2026
Last update posted
Jan 15, 2026

2024 – 2026

United States locations

U.S. sites
8
U.S. states
8
U.S. cities
8
Facility City State ZIP Site status
Alabama CRS (Site ID# 31788) Birmingham Alabama 35222
UCLA CARE Center CRS Los Angeles California 90035
Hope Clinic CRS Lawrenceville Georgia 30046
Johns Hopkins University CRS Baltimore Maryland 21287
Fenway Health (FH) CRS Boston Massachusetts 02215-4302
Weill Cornell Chelsea CRS New York New York 10011
Chapel Hill CRS (3201) Chapel Hill North Carolina 27599-7215
University of Pittsburgh CRS Pittsburgh Pennsylvania 15213

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06560684, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 15, 2026 · Synced Apr 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06560684 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →